Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 315

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 1A
Chunk 315
---
 “if-converted”) as its diluted net income per share during
the period. For the periods presented, potential dilutive securities had an anti-dilutive effect and were not included in the calculation
of diluted net loss per common share.

    F-12

Common
shares consisting of shares potentially dilutive that are excluded from the calculated of diluted earnings per share because they are
anti-dilutive as of December 31, 2024 and 2023 are as follows:

 Schedule of Diluted Earnings Per Share

    December 31, 2024  
    December 31, 2023 
  
    Warrants 
     8,192,967  
     1,760,350 
  
    Stock options 
     223,599  
     140,750 
  
    Total 
     8,416,566  
     1,901,100 

Note
5 – Other Current Assets

Other
current assets included the following as of December 31, 2024 and December 31, 2023:

 Schedule of Other Current Assets

    December 31,  
    December 31, 

    2024  
    2023 
  
    Federal and state income tax receivable (1)  
    $-  
    $73,069 
  
    Prepaid expenses and other current assets 
     276,563  
     316,718 
  
    Total other current assets 
    $276,563  
    $389,787 

    (1)
     
    Includes
    $50,000 for a federal refundable payroll tax credit, called the Employee Retention Tax Credit (“ERTC”) Tax Credit, which
    provides a credit to businesses who kept employees, or were negatively impacted, during the COVID-19 pandemic.

Note
6 – Property and Equipment

Property
and equipment at December 31, 2024 and December 31, 2023, consisted of the following:

 Schedule of Property and Equipment

    December 31,  
    December 31, 

    2024  
    2023 
  
    Office equipment – 5 year estimated life 
    $85,958  
    $81,340 
  
    Leasehold improvements – 2 year estimated life 
     60,783  
     60,783 
  
    Furniture and fixtures – 7 year estimated life